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SUMMARY – A 40-year-old male presented to emergency room with epileptic grand mal se-
izure. He had untreated hypertension, and prior diagnostic investigation showed duplex renal arteri-
es of the right kidney with hyperreninemia in the left renal vein. He was nonsmoker, with moderate 
alcohol intake. Neurologic examination was normal except for high blood pressure and tongue bite. 
Electroencephalogram was nonspecific. Nuclear magnetic resonance (NMR) showed vascular lesi-
ons in the white matter and infratentorially an expansive lesion with no postcontrast imbibition in 
the right cerebellar hemisphere. Neurosonography revealed hypoplasia of both internal carotid arte-
ries (ICA), mean diameter <2 mm, subtotal stenosis at the origin of both ICA, and development of 
collateral path, typical for moyamoya disease. Magnetic resonance angiography (MRA) and digital 
subtraction angiography (DSA) confirmed the neurosonography diagnosis. Immunologic tests for 
vasculitis were negative, while hematologic examination showed 4G allele for PAI-1. Serum lipids 
were elevated. We recommended neurosurgical operation of brain tumor. Histopathologic finding 
showed meningioma. This case is interesting because of the rare complex cerebrovascular disease, 
i.e. coexistence of hypoplasia of both ICA, bilateral subtotal stenosis of ICA, intracranial moyamoya 
disease, and brain tumor.
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Introduction
Moyamoya disease is a specific chronic cerebro-
vascular occlusive disease, first reported by Japanese 
surgeons in 1957. It is characterized by progressive 
stenosis and occlusion of the terminal portions of bi-
lateral internal carotid arteries and abnormal vascu-
lar network in the vicinity of the arterial occlusion1. 
There are 4 types: transient ischemic attack (TIA), 
ischemic, hemorrhagic, and epileptic2. In infants, 
children and adolescents it presents with ischemic at-
tacks or seizures. It rarely occurs in adults, usually in 
the third or fourth decade of life. Subarachnoid hem-
orrhage is the most common initial manifestation in 
adults. There are two peaks, at the age of 5 years and 
around the age of 40 years. Approximately 6000 cases 
of moyamoya disease have been reported across the 
world. The highest prevalence is in Japan, with a high-
er female to male ratio. In Asian patients, moyamoya 
mostly presents with cerebral hemorrhage, while in 
nonAsians it usually presents with ischemic stroke. 
Fifteen percent of all cases in Japan have familial oc-
currence, and recent studies suggest some responsible 
genetic foci on chromosomes 17 and 63,4. The symp-
toms include weakness of an arm, leg or both, head-
ache, convulsions, impaired mental development, 
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visual and speech disturbance, sensory impairment, 
involuntary movements or unsteady gait. The epileptic 
type of moyamoya disease is characterized mostly by 
focal seizures. Once the process of vascular occlusion 
begins, it tends to continue despite any known medi-
cal management. It leads to recurrent stroke and se-
vere impairment of daily living functions. Moyamoya 
disease is rarely asymptomatic.
Moyamoya disease should be distinguished from 
moyamoya syndrome, which is associated with neuro-
fibromatosis5, cranial irradiation6, Down’s syndrome7, 
morning glory anomaly8, systemic lupus erythemato-
sus (SLE)9, prothrombotic disorder10, or a congenital 
heart disease11, such as coarctation of aorta, ventricu-
lar septal defect, aortic and mitral valve stenoses, te-
tralogy of Fallot, and stenosis of coronary arteries. All 
this suggests that moyamoya disease might be an in-
tracranial manifestation of systemic arterial disorder.
The diagnosis of moyamoya disease includes char-
acteristic angiographic findings together with clini-
cal criteria. Nuclear magnetic resonance (NMR) and 
magnetic resonance angiography (MRA) should be 
performed for the diagnosis and follow up of moy-
amoya disease. Often, nuclear medicine studies such 
as single photon emission computerized tomogra-
phy (SPECT) are used to demonstrate the decreased 
blood and oxygen supply to the brain areas involved in 
the pathologic vascular process. 
The treatment of moyamoya disease is still un-
satisfactory. Cases with milder symptoms are usually 
treated conservatively, while more severe symptom-
atic cases are treated by revascularization procedures. 
Multiple revascularization procedures such as pial 
synangiosis, superficial temporal artery to middle 
cerebral artery bypass direct anastomosis are consid-
ered to be justified. Its efficacy for hemorrhagic type 
of disease remains uncertain. While symptoms may 
seem to improve immediately after the revasculariza-
tion procedure, it takes about 6-12 months before new 
vessels develop.
Case Report
A 40-year-old male was admitted to the Intensive 
Care Unit at University Department of Neurology, 
Sestre milosrdnice University Hospital, due to a grand 
mal epileptic seizure for the first time in his life. He 
had arterial hypertension since childhood, but did not 
take antihypertensive drugs. In 1991, he was hospital-
ized at University Department of Medicine, Zagreb 
University Hospital Center, for high blood pressure 
and nephrologic investigation including renal angiog-
raphy. Renal angiography revealed duplex renal arter-
ies in the right kidney and elevated renin in the left 
renal vein. He was taking lisinopril for a few months, 
but the medication was stopped because of side ef-
fects. He suffered from chronic low back pain with 
exacerbation two weeks before admission. He was a 
nonsmoker with moderate alcohol intake. 
Neurologic examination at admission was normal 
except for high blood pressure (190/100) and a tongue 
bite. Laboratory blood and urine results were normal 
Fig.1. Subtotal stenosis of the right internal carotid artery.
Fig.2. Carotid angiogram with a network of small 
anastomotic vessels at the base of the brain, rete mirabile. 
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except for elevated serum cholesterol and triglycerides. 
Electrocardiogram showed signs of left ventricular 
hypertrophy. Electroencephalogram was nonspecific. 
Computed tomography scan revealed chronic vascu-
lar lesions. Neurosonography revealed hypoplasia of 
both internal carotid arteries (ICA), mean diameter 
<2 mm, subtotal stenosis of both ICA with attenuated 
hemodynamics and development of collateral path, 
typical for moyamoya disease. Both vertebral and 
basilar arteries had normal hemodynamic spectrum. 
Transcranial Doppler sonography showed attenuated 
hemodynamics in the circle of Willis. Digital subtrac-
tion angiography (DSA) confirmed the diagnosis of 
moyamoya disease. Carotid angiogram showed typi-
cal rete mirabile, confirming suspicion of moyamoya 
disease. 
NMR showed T2 hyperintensive vascular lesions 
in the white matter and a T2 hyperintensive homo-
geneous lesion 2.5 cm in diameter infratentorially in 
the right cerebellar hemisphere, with no postcontrast 
imbibition. Morphological characteristics of this ex-
pansive process in the posterior cranial fossa were 
indicative of meningioma. Immunologic tests for vas-
culitis were negative, while hematologic examination 
showed 4G allele for plasminogen activator inhibi-
tor-1 (PAI-1), what implies a higher risk of deep vein 
thrombosis and myocardial infarction. Neurosurgeon 
recommended neurosurgical removal of the brain tu-
mor. The patient recovered fully and was advised to 
take antihypertensive, antiaggregation and antiepilep-
tic drugs. Histopathology of the brain tumor that was 
removed completely showed it to be a meningioma.
After 5-year follow up, the patient was free from 
any new ischemic events and seizures. Control NMR 
and MRA were unchanged.
Discussion
This case of a 40-year-old male patient with com-
plex cerebrovascular disease and brain tumor as a co-
incidental factor presenting with seizure is specific be-
cause of a combination of the epileptic and ischemic 
types of moyamoya disease. The seizure was obviously 
caused by multiple vascular ischemic lesions due to 
stenotic lesions of intracerebral arteries. Carotid an-
giogram showed extensive basal cerebral rete mirabile 
– a network of small anastomotic vessels at the base 
of the brain, around and distal to the circle of Wil-
lis, along with segmental stenosis or occlusion of the 
terminal parts of both internal carotid arteries. Six 
angiographic stages have been discribed1,12,13: stage 1 
shows narrowing of the carotid forks, stage 2 means 
moyamoya vessels at the base, stage 3 is characterized 
by more apparent moyamoya changes, stage 4 means 
reduced basal moyamoya vessels, in stage 5 reduction 
is more prominent, and in the last stage 6 moyamoya 
vessels disappear and collateral circulation is produced 
from external carotid arteries. According this staging, 
it was stage 3. The characteristic histopathologic fea-
tures are fibrocellular thickening of the intima contain-
ing proliferated smooth muscle cells and prominently 
tortuous and often duplicated internal elastic lamina. 
There is usually no atheromatous plaque in the arterial 
wall nor there are inflammatory signs. The etiology of 
moyamoya disease is still unclear. Even tough several 
linkage studies showed relations with gene loci, no 
specific locus has yet been identified. Investigations 
undertaken to better understand this rare condition 
have shown involvement of the cerebrospinal fluid 
(CSF) basic fibroblast growth factor (b-FGF) with 
receptor up-regulation and tumor growth factor beta 
1 in altering cerebral vasculature. Intimal thickening 
has also been postulated resulting from altered per-
meability due to enhanced prostaglandin release from 
the arterial smooth muscle14,15. The first conclusion 
Fig.3. Nuclear magnetic resonance showing expansive lesion 
in the right cerebellar hemisphere.
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was that infratentorial meningioma is an indepen-
dent factor, but there are several cases of moyamoya 
disease described in the literature where moyamoya 
was associated with different types of cranial tumors 
such as arteriovenous malformations, benign intrac-
ranial tumors in neurofibromatosis, cystic tumor of 
vermis, optic glioma and pituitary adenoma16. Men-
ingioma could be part of neurofibromatosis type II, a 
hereditary disorder that is connected with moyamoya 
disease. A study of the presence of numerical chromo-
some aberrations in meningioma tumors as revealed 
by fluorescence in situ hybridization17 showed an over-
all incidence of 76%. The most common abnormali-
ties were found in chromosome Y and chromosome 
22. Chromosome 17 was affected in 23% of patients. 
Deletion of a p17 chromosome leads to mutation of 
tumor suppression gene p53 and tumor transforma-
tion of normal meningoendothelial cells3,18,19. On the 
other hand, changes on chromosome 17 are mostly 
found in moyamoya disease. The coincidence of soli-
tary intracranial tumor and moyamoya disease could 
be connected with chromosome 17 aberrations.
The case presented is interesting because it suggests 
that not only neurofibromatosis type II as an inherited 
disease characterized by multiple multifocal tumors, 
mainly neurinoma, schwannoma and meningioma, 
but solitary intracranial tumors could also be associ-
ated with moyamoya disease. The coexistence of these 
two diseases could have a genetic origin connected 
with gene mutation located on chromosome 17. 
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Sažetak
BOLEST MOYAMOYA U BOLESNIKA S TUMOROM MOZGA: PRIKAZ SLUčAJA 
L. Dežmalj-Grbelja, J. Bošnjak, A. Lovrenčić-Huzjan, M. Ivica i V. Demarin
Muškarac u dobi od 40 godina pregledan je u hitnoj ambulanti zbog epileptičnog napada tipa grand mal. Bolovao je od 
neliječene hipertenzije, ranijom dijagnostičkom obradom verificirana je dvostruka bubrežna arterija desno i hipereninemija 
u lijevoj bubrežnoj veni. Bio je nepušač s umjerenom konzumacijom alkohola. Neurološki pregled je bio uredan osim povi-
šenih vrijednosti krvnog tlaka i traga ugriza jezika. Elektroencefalogram je bio nespecifičan. Magnetskom rezonancijom 
mozga nađene su vaskularne lezije u bijeloj tvari te infratentorijalno u desnoj cerebelarnoj hemisferi ekspanzivni proces 
bez postkontrastne imbibicije. Neurosonološkim ispitivanjem potvrđena je hipoplazija obiju unutarnjih karotidnih arterija 
(ACI) s prosječnim promjerom <2 mm, subtotalna stenoza polazišta obiju ACI i razvoj kolateralnog puta, što je tipično 
za bolest moyamoya. Magnetska angiografija (MRA) i digitalna subtrakcijska angiografija (DSA) su potvrdile neuro-
sonološku dijagnozu. Imunološki testovi za vaskulitis su bili negativni, dok je hematološkom obradom nađen 4G alel za 
plazminogen aktivator inhibitor-1 (PAI-1). Serumski lipidi su bili povišeni. Preporučili smo mu operaciju tumora mozga. 
Histopatološki nalaz je ukazivao na meningeom. Ovaj slučaj je zanimljiv zbog rijetke složene cerebrovaskularne bolesti, 
odnosno supostojeće hipoplazije obiju ACI, bilateralne subtotalne stenoze obiju ACI, intrakranijske bolesti moyamoya te 
tumora mozga. 
Ključne riječi: Novotvorine mozga – dijagnostika; Novotvorine mozga – ultrazvuk; Bolest moyamoya – dijagnostika; Bolest 
moyamoya – etiologija; Bolest moyamoya – patologija; Prikaz slučaja

